Globus Medical Stock Analysis (NYSE:GMED)
Globus Medical Analysis Video
View Globus Medical stock analysis video. This is our GMED analyst opinion covering the buy and sell arguments for GMED stock.
Globus Medical Inc Stock Rating (3.9/5)
Our Globus Medical stock opinion is based on fundamentals of the company. This Globus Medical stock analysis is based on latest Q4 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.
Should you buy GMED stock?
- The TTM operating margin was good at 27.2% for Globus Medical.
- Net margins came in at average 18.5% for Globus Medical over the last twelve months.
- The company has an operating cash flow which is 2.1 times the net income. We see this as a positive signal.
- Globus Medical generates a high return on invested capital of 20.7%.
- The LTM ROE of 13.4% for Globus Medical is attractive.
- Globus Medical has a healthy FCF (Free Cash Flow) margin of 24.9%.